Star Imaging And Path Lab Ltd

Star Imaging And Path Lab Ltd has announced that its Board of Directors will convene on November 13, 2026. The primary agenda item is to consider and approve the unaudited standalone and consolidated financial results for the half-year ended September 30, 2026, along with the associated limited review report. The company has also made this information available on its website.

Star Imaging and Path Lab Limited has been empanelled with the Municipal Corporation of Delhi (MCD) to provide diagnostic services. This empanelment allows the company to offer services to eligible beneficiaries at rates prescribed by the Central Government Health Scheme (CGHS). The validity of this empanelment is contingent upon the continued validity of the company's CGHS empanelment and adherence to its terms. The company anticipates this agreement will strengthen its business operations and expand its reach in the diagnostic services sector.

Star Imaging and Path Lab Limited has commenced commercial operations of a CT Scan diagnostic facility at R G Stone Urology & Laparoscopy Hospital in Faridabad, Haryana. This expansion is part of the company's strategy to broaden its diagnostic service network and enhance advanced imaging services in the region. The facility began operations on September 28, 2026, under a five-year tie-up arrangement with R G Stone Hospital. While the immediate financial impact is unquantifiable, it is expected to contribute to the company's diagnostic operations and revenues. The arrangement is not a related party transaction.

Star Imaging And Path Lab Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This closure is in effect from October 1, 2026, and will continue until 48 hours after the declaration of the unaudited financial results for the half-year ended September 30, 2026. The results will be both standalone and consolidated. The company will inform the stock exchanges about the board meeting date to approve these results in due course. Information will also be available on the company's website.

Star Imaging And Path Lab Ltd has issued a corrigendum to its Notice and Annual Report for the 22nd Annual General Meeting (AGM) for the Financial Year 2025-26. The company identified inadvertent typographical and clerical errors. Key corrections include changing a figure from '7.1 million' to '0.71 Million' and correcting the AGM date from '29 September 2025' to '29th September 2026'. Additionally, Note No. 27 regarding the calculation of Basic and Diluted Earnings Per Share (EPS) has been updated with revised figures for the years ended March 31, 2026, and March 31, 2028. The revised EPS for March 2026 is now stated as ₹12.24, and for March 2028 as ₹11.79. Specific EPS figures of ₹212.20 and ₹211.82 for Basic and Diluted EPS are also mentioned for March 2025. The company emphasizes that all other contents of the original documents remain unchanged and this corrigendum forms an integral part of them.

Star Imaging And Path Lab Ltd has announced its 22nd Annual General Meeting (AGM) will be held on Tuesday, September 29, 2025, at 02:00 P.M. (IST). The meeting will be conducted entirely through video conferencing (VC) or other audio-visual means (OAVM) in compliance with Ministry of Corporate Affairs (MCA) circulars. Key agenda items include the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026, along with the Board of Directors' and Auditors' reports. The company has confirmed that proxy appointments will not be available for this virtual meeting, but authorized representatives of body corporates can attend and vote via e-voting. NSDL will facilitate remote e-voting, participation, and e-voting during the AGM.

Star Imaging And Path Lab Ltd has released its Annual Report for the financial year 2025-26, along with the notice for its 22nd Annual General Meeting (AGM). The report details the company's overview, journey, service portfolio, geographic footprint, competitive strengths, and future outlook. It also includes statutory reports and financial statements (standalone and consolidated). The Chairman's message highlights steady progress in FY26 across operations, network expansion, and service diversification, with strategic priorities for FY27 including network expansion, deepening specialized diagnostics, increasing pathology integration, strengthening B2C franchise, pursuing PPP opportunities, and investing in technology and quality systems. The company has a history dating back to 1978 and operates across Delhi, Uttar Pradesh, and Nashik, with a diversified business model including B2G PPP contracts, B2C retail centers, and B2B partnerships.

Star Imaging and Path Lab Limited's Board of Directors met on August 28, 2026, approving key items for the upcoming 22nd Annual General Meeting (AGM) scheduled for September 29, 2026. The board approved the draft notice for the AGM, which will be held via Video Conferencing. They also fixed the cut-off date for e-voting as September 24, 2026, with remote e-voting commencing on September 26 and concluding on September 28, 2026. Additionally, the Board approved the Board's Report and Management Discussion and Analysis for the financial year ended March 31, 2026, and took note of the Secretarial Audit Report. The appointment of M/s Sheetal & Company as Scrutinizer and re-appointment as Secretarial Auditor for FY 2026-27 were approved. Mr. Suraj Verma was appointed as Internal Auditor for FY 2026-27. The Board also recommended the re-appointment of Ms. Neelam Ratra, Executive Director, who retires by rotation.

Star Imaging and Path Lab Limited's Board of Directors met on August 28, 2026, approving key items for the upcoming 22nd Annual General Meeting (AGM) scheduled for September 29, 2026. The Board approved the draft notice for the AGM, set the cut-off date for e-voting as September 24, 2026, with remote e-voting commencing September 26 and concluding September 28. They also approved the Board's Report and Management Discussion and Analysis for the financial year ended March 31, 2026. Additionally, the Board took note of the Secretarial Audit Report, appointed a scrutinizer for the AGM, re-appointed M/s Sheetal & Company as Secretarial Auditor for FY 2026-27, and appointed Mr. Suraj Verma as Internal Auditor for the same period. The re-appointment of Ms. Neelam Ratra as Executive Director was recommended to the members.

Star Imaging And Path Lab Ltd has filed its Monitoring Agency Report for the quarter ended June 30, 2026, as required by SEBI regulations. The report, issued by Infomerics Valuation and Rating Limited, confirms nil deviation from the objects for which the IPO proceeds of Rs. 55.66 crore were earmarked. The monitoring agency has declared that the report provides an objective view of the utilization of issue proceeds based on information provided by the issuer and other reliable sources. The report also includes declarations regarding the absence of conflicts of interest and a confirmation that it presents a true and fair view.